a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with NTLA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then NTLA could also see price increases.
Ticker / NAME | Correlation To ALEC | 1D Price Change % | ||
---|---|---|---|---|
ALEC | 100% | -10.61% | ||
NTLA - ALEC | 56% Loosely correlated | -3.65% | ||
DNLI - ALEC | 55% Loosely correlated | +2.78% | ||
BEAM - ALEC | 48% Loosely correlated | -8.55% | ||
VERV - ALEC | 48% Loosely correlated | -9.25% | ||
EDIT - ALEC | 47% Loosely correlated | -6.68% | ||
More |
Ticker / NAME | Correlation To ALEC | 1D Price Change % |
---|---|---|
ALEC | 100% | -10.61% |
biotechnology theme (248 stocks) | 55% Loosely correlated | +5.56% |
drugs theme (265 stocks) | 54% Loosely correlated | +5.37% |
therapeutics theme (57 stocks) | 50% Loosely correlated | +20.54% |
neurological theme (10 stocks) | 24% Poorly correlated | +0.84% |